Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Giovanni Salvatore Bruni"'
Autor:
Gaetano Facchini, Sandro Pignata, Lucia Cannella, Carmela Pisano, Davide Leopardo, Giovanni Salvatore Bruni
Publikováno v:
Cancer Letters. 303:73-83
Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50 years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d996539267a49622f701d436e1bee5
https://doi.org/10.1016/j.canlet.2011.01.026
https://doi.org/10.1016/j.canlet.2011.01.026
Autor:
Simona Losito, Carmela Pisano, Francesca Paola Magazzino, Giovanni Salvatore Bruni, Claudia Marchetti, Gaetano Facchini, Sandro Pignata
Publikováno v:
Expert Review of Anticancer Therapy. 10:47-60
Epithelial ovarian cancer is the fourth biggest cause of cancer-related death in women. Over recent decades, improvements have been made in treatment outcome in terms of response rate and survival. To date, intensive surgical staging and cytoreductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74b5047b5f34a244dd751ca3c8cba74
https://doi.org/10.1586/era.09.167
https://doi.org/10.1586/era.09.167
Autor:
C. Pisano, Sandro Pignata, Lucia Cannella, Davide Leopardo, Gaetano Facchini, Giovanni Salvatore Bruni
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 22
Serum cancer antigen 125 (CA125) is widely used in ovarian cancer to monitor the effectiveness of therapy both in first line and recurrence. It is also widely used during follow-up, where it is able to identify a percentage of patients with asymptoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a37cee1aa1aa4407e747a36d1caa0daa
https://pubmed.ncbi.nlm.nih.gov/22180398
https://pubmed.ncbi.nlm.nih.gov/22180398
Autor:
Gaetano Facchini, C. Pisano, Vincenzo Rosario Iaffaioli, Sandro Pignata, Giovanni Salvatore Bruni
Publikováno v:
European Journal of Cancer Supplements. 6(14)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac62733189f21ff3b07b6eae9366957
Autor:
Francesco Caponigro, Gaetano Apice, Rosario Vincenzo Iaffaioli, Amalia Milano, Giovanni Salvatore Bruni
Publikováno v:
Reviews on recent clinical trials. 1(1)
Gastrointestinal Stromal Tumor (GIST) is the most common mesenchymal neoplasm of the gastrointestinal tract, and it is characterized by the occurrence, in > 90 % of cases, of a gain of function mutation in the c-kit protooncogene. STI-571 (imatinib m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128e8c2bc42e53c0522d579c6733b0b4
https://pubmed.ncbi.nlm.nih.gov/18393778
https://pubmed.ncbi.nlm.nih.gov/18393778
Autor:
Emiddio, Barletta, Francesco, Fiore, Bruno, Daniele, Alessandro, Ottaiano, Roberto, D'Angelo, Ettore, Ferrari, Roberta, Formato, Anna, Tortoriello, Giacinto, Turitto, Giovanni Salvatore, Bruni, Sandro, Pignata, Rosario Vincenzo, Iaffaioli
Publikováno v:
Frontiers in bioscience : a journal and virtual library. 11
The present study was conducted to evaluate activity and toxicity of the FLEC (folinic acid 100 mg/m2; 5-fluorouracil 1000 mg/m2; carboplatin 300 mg/m2; epirubicin 60 mg/m2) schedule as second-line treatment for progressive locally advanced or metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc1fceb2a47ea093d1eea6c907660d4e
https://pubmed.ncbi.nlm.nih.gov/16146770
https://pubmed.ncbi.nlm.nih.gov/16146770
Autor:
Angelo Raffaele Bianco, Antonio Rossi, Cesare Gridelli, Luciana Rinaldi, Pasquale Incoronato, Francesco Scognamiglio, Pasquale Ruffolo, Giovanni Salvatore Bruni
Publikováno v:
Cancer chemotherapy and pharmacology. 37(6)
The present phase I study was designed to determine the maximum tolerated dose (MTD) of epirubicin given in combination with ifosfamide at a dose of 3 g/m2, recycled every 4 weeks, in patients with advanced non-small-cell lung cancer (NSCLC). A total
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff4b9504ff4fbc81f44b925940b2dc3
https://pubmed.ncbi.nlm.nih.gov/8612318
https://pubmed.ncbi.nlm.nih.gov/8612318
Autor:
Gaetano Facchini, Giovanni Salvatore Bruni, Simona Losito, F.P. Magazzino, Renato Franco, C. Pisano, Sandro Pignata, Stefano Greggi
Publikováno v:
European Journal of Cancer Supplements. 6:125
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9960d75f490e9373357b0a0d9abf9f
https://doi.org/10.1016/j.ejcsup.2008.06.051
https://doi.org/10.1016/j.ejcsup.2008.06.051
Autor:
Sandro Pignata, Gaetano Facchini, Claudia Marchetti, Carmela Pisano, Giovanni Salvatore Bruni
Publikováno v:
Scopus-Elsevier
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 421-426 (2009)
Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management, Vol 2009, Iss default, Pp 421-426 (2009)
Carmela Pisano, Giovanni S Bruni, Gaetano Facchini, Claudia Marchetti, Sandro PignataOncologia Medica, Dipartimento Uro-Ginecologico, Istituto Nazionale Tumori, Napoli, ItalyAbstract: Epidemiologic analysis reveals that the mortality rate from ovaria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c15ca25007ec27b0238a5080b506e424
http://www.scopus.com/inward/record.url?eid=2-s2.0-77949447507&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-77949447507&partnerID=MN8TOARS
